Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (Asia Pacific)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (Asia Pacific)
‘The chilling effect’ : how fear of ‘nudify’ apps and AI deepfakes is keeping Indian women off the internet
5/11/2025
Celebrity chefs urge Britons to ‘bang in some beans’ to boost legume consumption
5/11/2025
Propagate, repot, swap : how to fill your home with houseplants on a budget
5/11/2025
Just Stop Oil protesters convicted after being denied right to state climate facts
5/11/2025
Autumn in Alentejo : ancient city sites and golden vineyards in Portugal
5/11/2025
‘A shot of adrenaline’ : readers pass on 90s club classics to new generations
5/11/2025